July 22, 2013 -
CROS NT is an international Contract Research Organization and has been working with biometrics for clinical trials for over 20 years.
“As CROS NT continues to grow, it is becoming increasingly important to offer a broader technology portfolio to our customer base,” Paolo Morelli, CROS NT CEO said. “DATATRAK provides leading-edge technology, coupled with excellent customer service. As such they are a natural fit with our business, and I am pleased we have been able to expand our technology offering through the Partner Program.”
According to DATATRAK, the Connect Partner Program is a “collaboration between synergic companies to accelerate the drug development process.” The prime directive is to reduce study costs and further business development.
“We are pleased to welcome CROS NT into the DATATRAK Connect™ Partner Program,” Laurence P. Birch, DATATRAK’s Chairman of the Board and CEO said. “Our DATATRAK ONE™ technology offering will help facilitate their efforts to create a center of excellence for clinical trial data.”